New thymol-derived triazole exhibits promising activity against Trichophyton rubrum

Fungal infections have emerged worldwide, and azole antifungals are widely used to control these infections. However, the emergence of antifungal resistance has been compromising the effectiveness of these drugs. Therefore, the objective of this study was to evaluate the antifungal and cytotoxic act...

Full description

Saved in:
Bibliographic Details
Published in:Brazilian journal of microbiology Vol. 55; no. 2; pp. 1287 - 1295
Main Authors: de Sousa Cutrim, Thiago Antonio, Eloy, Mariana Alves, Barcelos, Fernando Fontes, Meireles, Leandra Martins, de Freitas Ferreira, Lara Chaves, Reis, Tatiana Alves, Gonçalves, Sarah Santos, Lacerda, Valdemar, Fronza, Marcio, Morais, Pedro Alves Bezerra, Scherer, Rodrigo
Format: Journal Article
Language:English
Published: Cham Springer International Publishing 01-06-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Fungal infections have emerged worldwide, and azole antifungals are widely used to control these infections. However, the emergence of antifungal resistance has been compromising the effectiveness of these drugs. Therefore, the objective of this study was to evaluate the antifungal and cytotoxic activities of the nine new 1,2,3 triazole compounds derived from thymol that were synthesized through Click chemistry. The binding mode prediction was carried out by docking studies using the crystallographic structure of Lanosterol 14α-demethylase G73E mutant from Saccharomyces cerevisiae . The new compounds showed potent antifungal activity against Trichophyton rubrum but did not show relevant action against Aspergillus fumigatus and Candida albicans . For T. rubrum , molecules nº 5 and 8 showed promising results, emphasizing nº 8, whose fungicidal and fungistatic effects were similar to fluconazole. In addition, molecule nº 8 showed low toxicity for keratinocytes and fibroblasts, concluding that this compound demonstrates promising characteristics for developing a new drug for dermatophytosis caused by T. rubrum , or serves as a structural basis for further research.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1517-8382
1678-4405
1678-4405
DOI:10.1007/s42770-024-01295-0